首页> 外国专利> HUMAN MELANOMA CELL LINE MEL IBR EEMC INTENDED FOR DEVELOPMENT OF IMMUNOLOGICAL APPROACHES IN TREATING MELANOMA

HUMAN MELANOMA CELL LINE MEL IBR EEMC INTENDED FOR DEVELOPMENT OF IMMUNOLOGICAL APPROACHES IN TREATING MELANOMA

机译:人黑素瘤细胞系MEL IBR EEMC旨在开发治疗黑素瘤的免疫学方法

摘要

FIELD: biotechnology.;SUBSTANCE: invention relates to biotechnology, namely to obtaining cell lines intended for development of immunological approaches in treating melanoma, and can be used in medicine. Cell line of human skin melanoma mel Ibr EEMS is obtained from cell line of human skin melanoma mel Ibr. Obtained cell line is stored in Russian national collection of Industrial Microorganisms (VKPM) of FSUE GosNIIGenetika under registration number N-157.;EFFECT: invention enables to obtain a cell line of human skin melanoma, which has stable cultural and morphological characteristics and is characterised by the expression of antigens of class I histocompatibility, differentiation markers CD133, CD105, CD44 and absence of class II histocompatibility antigens.;1 cl, 1 tbl
机译:技术领域本发明涉及生物技术,即获得用于开发用于治疗黑素瘤的免疫学方法的细胞系,并且可以用于医学中。人皮肤黑素瘤细胞系EEMS是从人皮肤黑素瘤细胞系获得的。将获得的细胞系保存在俄罗斯国家FSUE GosNIIGenetika的工业微生物(VKPM)中,注册号为N-157。效果:本发明能够获得人皮肤黑色素瘤细胞系,该细胞系具有稳定的培养和形态学特征并具有特征通过表达I类组织相容性抗原,分化标志物CD133,CD105,CD44和不存在II类组织相容性抗原来表达; 1 cl,1 tbl

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号